Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome
Open Access
- 18 February 2020
- journal article
- research article
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 58 (8) , 1291-1301
Abstract
Background: The increased secretion of anti-Müllerian hormone (AMH) by the growing follicles has been supposed as a determinative feature of polycystic ovary syndrome (PCOS). The diagnostic performance of AMH in PCOS is superior compared to the free androgen index (FAI) and luteinizing hormone (LH)/follicle-stimulating hormone (FSH) quotient. We established age-dependent reference ranges to further improve the diagnostic performance of AMH. Methods: In a cross-sectional study, in samples of 4712 reproductive age patients, ranging from 14 to 50 years, BMI, AMH and other reproductive hormones were determined by immunoassay or tandem mass spectrometry (LC-MS/MS) to calculate age-specific reference ranges and the diagnostic performance. Results: Age-specific diagnostic performances for Elecsys® AMH, FAI and LH/FSH ratio were established in the reference group. No significant difference in BMI was found between the groups. AMH values were significantly negatively correlated with age (r = −0.628, p < 0.001) in patients with normal ovarian function, but there was no correlation between age and AMH levels in PCOS patients (r = − 0.041, p < 0.174). In all the study groups, AMH showed a weak correlation between FAI and LH/FSH ratio (r = 0.302, p < 0.001 and r = 0.434, p < 0.001, respectively). The sensitivity/specificity for AMH, FAI and LH/FSH ratio were 89/96%, 71/69% and 75/72%, respectively, according to the Youden index. Conclusions: We determined the age-dependent reference ranges for serum AMH levels in a large population-based study and calculated the age-specific diagnostic performance of FAI and LH/FSH ratio, which allows physicians to evaluate patients with PCOS who have normal AMH levels. AMH is suggested as the strongest diagnostic marker in patients with PCOS compared to FAI and LH/FSH ratio.Keywords
This publication has 38 references indexed in Scilit:
- Multicenter analytical performance evaluation of a fully automated anti-Müllerian hormone assay and reference interval determinationClinical Biochemistry, 2016
- Role of Anti-Müllerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a reviewReproductive Biology and Endocrinology, 2015
- Testosterone, free testosterone, and free androgen index in women: Reference intervals, biological variation, and diagnostic value in polycystic ovary syndromeClinica Chimica Acta, 2015
- Performance of the two new fully automated anti-Müllerian hormone immunoassays compared with the clinical standard assayHuman Reproduction, 2015
- First fully automated immunoassay for anti-Müllerian hormoneClinical Chemistry and Laboratory Medicine (CCLM), 2014
- Anti-Mullerian hormone (AMH): what do we still need to know?Human Reproduction, 2009
- Granulosa Cell Production of Anti-Müllerian Hormone Is Increased in Polycystic OvariesThe Journal of Clinical Endocrinology & Metabolism, 2007
- Anti-Müllerian hormone and folliculogenesisMolecular and Cellular Endocrinology, 2005
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)Human Reproduction, 2004
- A New Biometrical Procedure for Testing the Equality of Measurements from Two Different Analytical Methods. Application of linear regression procedures for method comparison studies in Clinical Chemistry, Part IClinical Chemistry and Laboratory Medicine (CCLM), 1983